UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,819,000 | -1.8% | 50,605 | +0.9% | 0.01% | 0.0% |
Q1 2019 | $1,852,000 | +34.6% | 50,135 | +56.9% | 0.01% | +25.0% |
Q4 2018 | $1,376,000 | -4.6% | 31,950 | +4.5% | 0.00% | 0.0% |
Q3 2018 | $1,443,000 | -6.5% | 30,563 | -1.5% | 0.00% | 0.0% |
Q2 2018 | $1,544,000 | -1.1% | 31,033 | -1.2% | 0.00% | 0.0% |
Q1 2018 | $1,561,000 | +123.0% | 31,416 | +67.0% | 0.00% | +100.0% |
Q4 2017 | $700,000 | – | 18,816 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |